GE HealthCare Technologies opened higher at $77.43, compared with its previous close of $76.42. In the last trading session, the stock traded between $76.44 and $78.22. It showed a sideways intraday trend.
An investment of $100 made 4 years ago in GE HealthCare Technologies is now worth
$ 127.08
giving a profit of
$ 27.08 (27.08%)
Note: Past profits do not guarantee future returns.
Rating from 13 Analysts
Today's Change
+$0.45 (+0.59%)
Day High
$78.22
Day Low
$76.44
Day Open
$77.43
Prev Close
$76.42
Volume
14,52,322
1W Return
7.64%
1M Return
15.66%
3M Return
6.87%
6M Return
29.22%
1Y Return
-0.66%
Market Cap ($ Mn)
34,755
PE Ratio
16.49
PB Ratio
2.95
PEG Ratio
27.04
ROE
22.57%
ROCE
12.49%
EPS (TTM)
$1.36
1 Week
7.64%
1 Month
15.66%
3 Months
6.87%
6 Months
29.22%
9 Months
-2.43%
GE HealthCare launches global trials for StarGuide GX theranostics system
Five global institutions evaluate StarGuide GX SPECT/CT across three continents. More than 1,000 patient studies conducted prior to EANM 2026 Annual Meeting. System offers up to 2.67 times system volume sensitivity with Low-Medium Energy collimator. StarGuide GX holds CE Mark but remains 510(k) pending with U.S. FDA.
10 days agoGE HealthCare cyclotron gets CE Mark; adds Copper-64 support
MINItrace Magni cyclotron receives CE Mark for local PET isotope production. PETtrace platform expands to support Copper-64 alongside Gallium-68. System designed for compact, self-shielded in-house radiopharmacy operations. Copper-64 addition aids research into theranostic pairs for cancer treatment.
15 days agoGE HealthCare securities fraud probe continues after Q1 miss and CFO exit
GE HealthCare faces continued securities fraud investigation by Glancy Prongay Wolke & Rotter LLP. Q1 adjusted EPS reported at $0.99, missing prior expectations. Full-year 2026 adjusted EPS guidance cut to $4.80-$5.00 from $4.95-$5.15. Shares fell 13.2% to $59.49 following April 29 guidance revision. CFO Jay Saccaro announced departure on July 23, 2026.
25 days agoGE HealthCare to buy Sofie for $1 billion to expand imaging business
GE HealthCare Technologies Inc plans to acquire Sofie for nearly $1 billion. The deal targets expansion of the medical-imaging business segment. Acquisition aims to strengthen GE HealthCare's position in healthcare technology.
25 days agoGE HealthCare declares $0.04 per share dividend for Q3 2026
GE HealthCare declared a $0.04 per share dividend for Q3 2026. The payout marks a 14% increase from the previous quarter. Shareholders of record as of October 23, 2026 are eligible. Dividend payment is scheduled for November 13, 2026.
1mo agoThird law firm probes GE HealthCare after Q1 miss and guidance cut
Law Offices of Howard G. Smith joins probes by Glancy Prongay and Frank R. Cruz into GE HealthCare. Investigations focus on potential securities violations related to Q1 2026 earnings miss and guidance cut. Company reported adjusted EPS of $0.99 for Q1 2026 and lowered full-year guidance to $4.80-$5.00. Shares fell 13.2% to $59.49 on April 29, 2026, following the earnings announcement.
1mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $104.57 | +1.88% | $1,80,946.15M | 36.28 | |
| $448.76 | +1.03% | $1,55,559.96M | 42.73 | |
| $97.11 | +2.46% | $1,24,220.20M | 24.46 | |
| $311.75 | +2.55% | $1,19,578.88M | 34.27 | |
| $42.69 | +0.61% | $61,867.63M | 18.96 | |
| $94.44 | +2.90% | $54,435.22M | 53.70 | |
| $198.34 | +1.63% | $54,025.24M | 44.07 | |
| $252.83 | +1.06% | $35,557.76M | 23.04 | |
| $71.13 | +1.86% | $34,384.24M | 54.55 | |
| $79.93 | +1.67% | $30,162.46M | 36.04 | |
| $416.67 | +3.23% | $29,323.57M | 43.21 | |
| $32.00 | -1.14% | $28,075.23M | 89.05 |
An investment of $100 made 4 years ago in GE HealthCare Technologies is now worth
$ 127.08
giving a profit of
$ 27.08 (27.08%)
Note: Past profits do not guarantee future returns.
